LNTH Logo

Lantheus Holdings, Inc. (LNTH) 

NASDAQ
Market Cap
$6.43B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
751 of 958
Rank in Industry
46 of 58

Largest Insider Buys in Sector

LNTH Stock Price History Chart

LNTH Stock Performance

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable …

Insider Activity of Lantheus Holdings, Inc.

Over the last 12 months, insiders at Lantheus Holdings, Inc. have bought $0 and sold $19.54M worth of Lantheus Holdings, Inc. stock.

On average, over the past 5 years, insiders at Lantheus Holdings, Inc. have bought $141,200 and sold $13.07M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,000 shares for transaction amount of $18,600 was made by Maeusli Heinz Christoph (director) on 2021‑03‑05.

List of Insider Buy and Sell Transactions, Lantheus Holdings, Inc.

2024-11-15SaleCFO and Treasurer
10,000
0.0143%
$81.20$812,000+17.49%
2024-11-14SalePresident
2,000
0.0028%
$79.65$159,3000.00%
2024-11-08Saledirector
11,487
0.0167%
$87.16$1M+2.32%
2024-08-21Saledirector
1,000
0.0014%
$98.52$98,520+4.07%
2024-08-14SaleSee Remarks
2,500
0.0036%
$97.54$243,8500.00%
2024-08-12Saledirector
15,500
0.0223%
$96.48$1.5M+8.62%
2024-08-08SalePresident
2,000
0.0028%
$96.39$192,780+7.36%
2024-08-02Saledirector
10,481
0.0148%
$95.50$1M+4.63%
2024-07-16SaleChief Accounting Officer
1,796
0.0041%
$124.96$224,423-11.40%
2024-07-15SaleChief Accounting Officer
341
0.0008%
$123.15$41,9940.00%
2024-07-10Saledirector
12,530
0.0219%
$95.04$1.19M0.00%
2024-06-13SaleChief Accounting Officer
341
0.0005%
$79.77$27,202+26.87%
2024-05-31SalePresident
1,179
0.0017%
$80.82$95,287+20.52%
2024-05-30SaleSee Remarks
12,873
0.0184%
$79.86$1.03M+22.38%
2024-05-28Saledirector
2,500
0.0036%
$78.50$196,250+23.67%
2024-05-28Saledirector
18,373.33
0.0264%
$79.19$1.45M+23.67%
2024-05-13SaleChief Accounting Officer
341
0.0005%
$76.89$26,219+24.47%
2024-04-15SaleChief Accounting Officer
341
0.0005%
$61.24$20,883+51.03%
2024-03-15SaleCFO and Treasurer
20,000
0.0301%
$60.00$1.2M+52.88%
2024-03-13SaleChief Accounting Officer
341
0.0005%
$60.48$20,624+48.53%

Insider Historical Profitability

41.74%
Maeusli Heinz Christophdirector
23340
0.0336%
$92.4581+41.74%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$524.83M12.178.43M-0.41%-$2.14M0.01
The Vanguard Group$458.27M10.627.36M+5.59%+$24.26M0.01
Janus Henderson$238.95M5.543.84M-2.75%-$6.74M0.12
State Street$154.96M3.592.49M+3.79%+$5.66M0.01
Westfield Capital Management Co Lp$121.87M2.831.96M+25.26%+$24.57M0.64
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.